German drugmaker files $21.6M IPO for skin cancer drug
German biotech Biofrontera is looking to raise $21.6 million in a US IPO to fund development and marketing of its late-stage skin care drug. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
